Lobimopt 5 mg, 0,3 mg Eye Drop
PDF Leaflet Revision Date: 11 Apr 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of intraocular pressure in open-angle glaucoma or ocular hypertension.
Dosage (summary)
1 drop in affected eye(s) once daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use with caution in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Additive effects with systemic beta-blockers
- Increased hypoglycaemic effect with antidiabetics
Contraindications
- Hypersensitivity to active substances
- Reactive airway disease
- Severe cardiac conditions
Common side effects
- Conjunctival hyperaemia
- Headache
- Eye irritation
Counselling Points
- Avoid contact with skin
- Monitor for eye changes
- Remove contact lenses before use
Serious warnings
- Potential for systemic absorption
- Caution in patients with cardiovascular diseases
Important Disclaimer
The Lobimopt 5 mg, 0,3 mg Eye Drop professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
